Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New-Onset Type 2 Diabetes Mellitus

Objectives We intend to investigate the feasibility of using repaglinide as initial therapy in patients with newly diagnosed type 2 diabetes mellitus naive to the oral anti-hyperglycemic agents by validating the effects of repaglinide on glycemic control (HbA1c) in comparison with metformin monother...

Descripción completa

Detalles Bibliográficos
Autores principales: Younas, Amna, Riaz, Junaid, Chughtai, Tamoor, Maqsood, Hamza, Younus, Shifa, Qasim, Muhammad, Saim, Muhammad, Qazi, Shaheryar, Khaliq, Muhammad, Fatima, Mahnoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926176/
https://www.ncbi.nlm.nih.gov/pubmed/33680590
http://dx.doi.org/10.7759/cureus.13045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926176/
https://www.ncbi.nlm.nih.gov/pubmed/33680590
http://dx.doi.org/10.7759/cureus.13045

Ejemplares similares